Maiworm brings over 20 years of energy and finance experience to his new role, having previously served as the Chief ...

The collaboration revenue from net sales of zurzuvae was $36.1 million for the full year 2024 and $13.8 million for the first ...

Enliven Therapeutics, Inc. (NASDAQ: ELVN) has announced the pricing of its underwritten public offering of 8,394,737 shares ...

Balaji's appointment is seen as a significant addition to Blackline's board, with his expertise in scaling businesses, ...

The regular quarterly dividends on the Series D preferred stock and the Series E preferred stock represented by the ...

Korn Ferry (NYSE:KFY) has announced a quarterly cash dividend of $0.48 per share, payable on July 31, 2025, to shareholders ...

MCD has an average analyst rating of buy and is -10.43% away from its mean target price of $328.75 per share Its trailing ...

Verve Therapeutics is a clinical-stage company developing genetic medicines for cardiovascular disease, with its lead program ...

Shivanandan's appointment is expected to bring valuable perspective to Iridium's board, given her early career roots in ...

Megan Graves, who has served as Chief Executive Officer of Hamilton Re since 2020, has decided to retire from the company, ...

D-Wave Quantum Inc. has recently announced a strategic partnership with Yonsei University and Incheon Metropolitan City, ...

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has announced positive topline results from its phase 2 Explore-CKD trial of ...